As scientists race to develop a COVID-19 vaccine, some experts warned that syringes could become the next face masks – coveted items in short supply able to plunge the market into chaos. But it appears that the federal government and health care supply companies learned a lesson from the mad scramble for masks and other personal protective equipment that came to symbolize the early weeks of the pandemic. Rather than wait for a viable vaccine to stock up on syringes, the federal government is securing them now. To date, it has signed at least $260 million in contracts for their production. |